Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.19.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2018
Dec. 31, 2017
Current Assets    
Cash $ 58,488 $ 358,303
Accounts receivable, net 457,745 188,067
Accounts receivable - related parties, net of allowance of $514,087 at each of December 31, 2018 and 2017, respectively 71,650 851,016
Advances to employees 281,783 284,496
Inventory 1,033,895 1,388,666
Real estate lots held for sale 139,492 151,906
Prepaid expenses and other current assets 193,360 159,465
Total Current Assets 2,236,413 3,381,919
Property and equipment, net 2,972,364 4,532,890
Prepaid foreign taxes, net 369,590 342,312
Investment - related parties 7,840 26,401
Deposits 61,284 61,284
Total Assets 5,647,491 8,344,806
Current Liabilities    
Accounts payable 497,817 415,318
Accrued expenses, current portion 1,185,367 1,000,521
Deferred revenue 1,038,492 1,732,664
Loans payable, current portion, net of debt discount 871,106 256,724
Convertible debt obligations, net of debt discount 2,732,654 20,000
Current portion of other liabilities 99,901 19,156
Total Current Liabilities 6,425,337 3,444,383
Accrued expenses, non-current portion 57,786 247,515
Other liabilities, non-current portion 11,474
Loans payable, non-current portion, net of debt discount 234,791 634,930
Total Liabilities 6,717,914 4,338,302
Commitments and Contingencies
Series B convertible redeemable preferred stock, par value $0.01 per share, 902,670 shares authorized, issued and outstanding at December 31, 2018 and 2017, respectively. Liquidation preference of $9,658,278 at December 31, 2018. 9,026,824 9,026,824
Stockholders' Deficiency    
Common stock, par value $0.01 per share; 80,000,000 shares authorized; 46,738,532 and 43,067,546 shares issued and 46,687,999 and 43,063,135 shares outstanding as of December 31, 2018 and 2017, respectively. 467,384 430,674
Additional paid-in capital 83,814,442 80,902,967
Accumulated other comprehensive loss (13,110,219) (10,795,810)
Accumulated deficit (81,222,499) (75,544,081)
Treasury stock, at cost, 50,533 and 4,411 shares at December 31, 2018 and 2017, respectively. (46,355) (14,070)
Total Stockholders' Deficiency (10,097,247) (5,020,320)
Total Liabilities, Temporary Equity and Stockholders' Deficiency 5,647,491 8,344,806
Series A Convertible Preferred Stock [Member]    
Stockholders' Deficiency    
Preferred stock, 11,000,000 shares authorized; Series A convertible preferred stock, par value $0.01 per share; 10,097,330 shares authorized; no shares are available for issuance.